Hale Therapeutics
Philadelphia
About Hale Therapeutics
Hale Therapeutics provides a device and app to help people quit smoking by reducing nicotine intake gradually.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Nov 2021)
- Website: tryhale.com
Industries & Categories
Apps, Biotechnology, Health Care, Software
Social Profiles
Canonical: https://fsome.com/organization/hale-therapeutics-130362 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.